Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)

Journal of Neuroimmunology

Volumn 206, Issue 1-2, 2009, Pages 121-124

  Zhang, Rongzhen ^a   Miller, Robert G ^b   Gascon, Ron ^a   Champion, Stacey ^b   Katz, Jonathan ^b   Lancero, Mariselle ^a   Narvaez, Amy ^a   Honrada, Ronald ^a   Ruvalcaba, David ^a   McGrath, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis (ALS); Lipopolysaccharide (LPS); Monocyte macrophage activation

Indexed keywords

ACETYLSALICYLIC ACID; ENDOTOXIN; IBUPROFEN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; RILUZOLE;

ADULT; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; CIRCULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREACTIVITY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MONOCYTE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ENDOTOXINS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES;

EID: 58149279447     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.09.017     Document Type: Article

References (33)

1. Alexianu M.E., Kozovska M., and Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57 (2001) 1282-1289
2. Babu G.N., Kumar A., Chandra R., Puri S.K., Kalita J., and Misra U.K. Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India. Neurochem. Res. 33 (2008) 1145-1149
3. Baron P., Bussini S., Cardin V., Corbo M., Conti G., Galimberti D., Scarpini E., Bresolin N., Wharton S.B., Shaw P.J., and Silani V. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 32 (2005) 541-544
4. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., and Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 16 (1999) 851-863
5. Beutler B., Milsark I.W., and Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229 (1985) 869-871
6. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., and Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 (2006) 1365-1371
7. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol. Sci. 124 (1994) 96-107 Suppl
8. Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., and Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J. Neurol. Sci. 169 (1999) 13-21
9. Cereda C., Baiocchi C., Bongioanni P., Cova E., Guareschi S., Metelli M.R., Rossi B., Sbalsi I., Cuccia M.C., and Ceroni M. TNF and sTNFR1/2 plasma levels in ALS patients. J. Neuroimmunol. 194 (2008) 123-131
10. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., and Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25 (2005) 9275-9284
11. Danner R.L., Elin R.J., Hosseini J.M., Wesley R.A., Reilly J.M., and Parillo J.E. Endotoxemia in human septic shock. Chest 99 (1991) 169-175
12. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
13. Flo T.H., Halaas O., Lien E., Ryan L., Teti G., Golenbock D.T., Sundan A., and Espevik T. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164 (2000) 2064-2069
14. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., and Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177 (1993) 547-550
15. Graves M.C., Fiala M., Dinglasan L.A., Liu N.Q., Sayre J., Chiappelli F., van Kooten C., and Vinters H.V. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 5 (2004) 213-219
16. Henkel J.S., Engelhardt J.I., Siklos L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., and Appel S.H. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55 (2004) 221-235
17. Hickey M.J., Issekutz A.C., Reinhardt P.H., Fedorak R.N., and Kubes P. Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ. Res. 83 (1998) 1124-1131
18. Marchant A., Bruyns C., Vandenabeele P., Abramowicz D., Gerard C., Delvaux A., Ghezzi P., Velu T., and Goldman M. The protective role of interleukin-10 in endotoxin shock. Prog. Clin. Biol. Res. 388 (1994) 417-423
19. McGeer P.L., and McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26 (2002) 459-470
20. Nguyen M.D., D'Aigle T., Gowing G., Julien J.P., and Rivest S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24 (2004) 1340-1349
21. Okusawa S., Gelfand J.A., Ikejima T., Connolly R.J., and Dinarello C.A. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81 (1988) 1162-1172
22. Ono S., Hu J., Shimizu N., Imai T., and Nakagawa H. Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J. Neurol. Sci. 187 (2001) 27-34
23. Poloni M., Facchetti D., Mai R., Micheli A., Agnoletti L., Francolini G., Mora G., Camana C., Mazzini L., and Bachetti T. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 287 (2000) 211-214
24. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., and Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55 (2007) 453-462
25. Ramani M., Ollivier V., Khechai F., Vu T., Ternisien C., Bridey F., and de Prost D. Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes. FEBS Lett. 334 (1993) 114-116
26. Sekizawa T., Openshaw H., Ohbo K., Sugamura K., Itoyama Y., and Niland J.C. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J. Neurol. Sci. 154 (1998) 194-199
27. Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., and Appel S.H. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 62 (2004) 1758-1765
28. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
29. Tobias P.S., Tapping R.I., and Gegner J.A. Endotoxin interactions with lipopolysaccharide-responsive cells. Clin. Infect. Dis. 28 (1999) 476-481
30. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R.J., Fahey T.J., Zentella A., Albert J.D., et al. Shock and tissue injury induced by recombinant human cachectin. Science 234 (1986) 470-474
31. Wilms H., Sievers J., Dengler R., Bufler J., Deuschl G., and Lucius R. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J. Neuroimmunol. 144 (2003) 139-142
32. Zhang R., Gascon R., Miller R.G., Gelinas D.F., Mass J., Hadlock K., Jin X., Reis J., Narvaez A., and McGrath M.S. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 159 (2005) 215-224
33. Zhang R., Gascon R., Miller R.G., Gelinas D.F., Mass J., Lancero M., Narvaez A., and McGrath M.S. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 179 (2006) 87-93